Login / Signup

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.

Linnea ThorlaciusJohn R IngramAmit GargBente VillumsenSolveig EsmannJoslyn S KirbyAlice B GottliebJoseph F MerolaRobert DellavalleRobin ChristensenGregor B E Jemec
Published in: BMJ open (2017)
The study will be performed according to the Helsinki declaration. All results from the study, including inconclusive or negative results, will be published in peer-reviewed indexed journals. The study will involve different stakeholder groups to ensure that the developed COS will be suitable and well accepted.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • type diabetes
  • systematic review
  • hidradenitis suppurativa
  • adipose tissue
  • phase ii